Estrogen Abolishes Protective Effect of Erythropoietin against Cisplatin-Induced Nephrotoxicity in Ovariectomized Rats. (6th November 2012)
- Record Type:
- Journal Article
- Title:
- Estrogen Abolishes Protective Effect of Erythropoietin against Cisplatin-Induced Nephrotoxicity in Ovariectomized Rats. (6th November 2012)
- Main Title:
- Estrogen Abolishes Protective Effect of Erythropoietin against Cisplatin-Induced Nephrotoxicity in Ovariectomized Rats
- Authors:
- Pezeshki, Zahra
Nematbakhsh, Mehdi
Mazaheri, Safoora
Eshraghi-Jazi, Fatemeh
Talebi, Ardeshir
Nasri, Hamid
Safari, Tahereh
Mansouri, Azam
Ashrafi, Farzaneh - Other Names:
- Stracke M. Academic Editor.
Yu Y. Academic Editor. - Abstract:
- Abstract : Introduction . Nephrotoxicity is one the side effect of cisplatin therapy and erythropoietin has been candidate as a nephroprotectant agent. However, its nephroprotective effect when it is accompained with estrogen has not been studied in female. Methods . 27 ovariectomized female Wistar rats divided into five groups. Groups 1 & 2 received estradiol valerate (0.5 mg/kg/week) for four weeks, and single dose of cisplatin (7 mg/kg, ip) was administrated at the end of week 3. Then the group 1 was treated with erythropoietin (100 U/kg/day), and the group 2 received vehicle during week 4. Groups 3 and 4 were treated similar to group 1 and 2, except for placebo instead estradiol valerate. Group5 (negative control) received placebo during the study. Animals were killed at the end of week 4. Results . In non-erythropoietin treated rats, cisplatin significantly increased the serum levels of blood urea nitrogen and creatinine (P < 0.05 ). However, these biomarkers significantly decreased by erythropoietin (P < 0.05 ). The weight loss, kidney weight, and kidney tissue damage score in rats treated with cisplatin but without estradiol were significantly less than the values in similar group when estradiol was present (P < 0.05 ). Conclusion . It seems that erythropoietin could protect the kidney against cisplatin-induced nephrotoxicity. This protective effect was not observed when estrogen was present.
- Is Part Of:
- ISRN oncology. Volume 2012(2012)
- Journal:
- ISRN oncology
- Issue:
- Volume 2012(2012)
- Issue Display:
- Volume 2012, Issue 2012 (2012)
- Year:
- 2012
- Volume:
- 2012
- Issue:
- 2012
- Issue Sort Value:
- 2012-2012-2012-0000
- Page Start:
- Page End:
- Publication Date:
- 2012-11-06
- Subjects:
- Oncology -- Periodicals
Neoplasms
Oncology
Periodicals
616.994 - Journal URLs:
- https://www.hindawi.com/journals/isrn/contents/isrn.oncology/ ↗
- DOI:
- 10.5402/2012/890310 ↗
- Languages:
- English
- ISSNs:
- 2090-5661
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 21960.xml